Rachel Klemovitch, Assistant Editor01.25.24
IlluminOss Medical announces benchmark achievement of having placed 10,000 of its light-cured, patient conforming implants. The IlluminOss implants are designed to treat geriatric fractures through a minimally invasive surgical procedure.
It is estimated that 1.5 million of the elderly population suffer “fragility fractures,” injuries that are difficult to treat traditionally with metal plates and screws due to brittle bones being unable to hold secure fixations. The nonsurgical treatment option involves a sling or cast that may require months of healing-time, potentially causing a downwards spiral in patient health from immobility.
IlluminOss implants provide fracture stability designed to allow patients to quickly regain mobilization.
"The IlluminOss implant can augment delicate bone to support and stabilize fractures. Once the implant is within the bone, the blue light starts a chemical reaction to create a strong polymer. It turns fragile bone into strong bone," Dr. Steve Morgan, Colorado-based orthopedic trauma surgeon told the press. "I found the IlluminOss implant minimizes complications in challenging fractures such as a geriatric humerus."
The technology contains an expanding balloon-like implant placed inside a fractured bone that is infused with the implant via a light-curing liquid. The blue light is transmitted to the implant through optical fibers that convert the liquid into a polymer that creates a strong core for the bone.
If additional fixation is required, the IlluminOss implant supplies the sufficient strength required for plates and screws to be fastened to the bone.
CEO and orthopedic surgeon of Ortho Rhode Island, Dr. Michael Bradley commented, "IlluminOss is a cutting-edge technology that has redefined the treatment of fractures. It offers almost instant strength and stability to the fracture site through a minimally invasive approach, allowing a fast return to activities of daily life."
It is estimated that 1.5 million of the elderly population suffer “fragility fractures,” injuries that are difficult to treat traditionally with metal plates and screws due to brittle bones being unable to hold secure fixations. The nonsurgical treatment option involves a sling or cast that may require months of healing-time, potentially causing a downwards spiral in patient health from immobility.
IlluminOss implants provide fracture stability designed to allow patients to quickly regain mobilization.
"The IlluminOss implant can augment delicate bone to support and stabilize fractures. Once the implant is within the bone, the blue light starts a chemical reaction to create a strong polymer. It turns fragile bone into strong bone," Dr. Steve Morgan, Colorado-based orthopedic trauma surgeon told the press. "I found the IlluminOss implant minimizes complications in challenging fractures such as a geriatric humerus."
The technology contains an expanding balloon-like implant placed inside a fractured bone that is infused with the implant via a light-curing liquid. The blue light is transmitted to the implant through optical fibers that convert the liquid into a polymer that creates a strong core for the bone.
If additional fixation is required, the IlluminOss implant supplies the sufficient strength required for plates and screws to be fastened to the bone.
CEO and orthopedic surgeon of Ortho Rhode Island, Dr. Michael Bradley commented, "IlluminOss is a cutting-edge technology that has redefined the treatment of fractures. It offers almost instant strength and stability to the fracture site through a minimally invasive approach, allowing a fast return to activities of daily life."